Most Recent
Wyeth says generic Effexor registration ‘not legitimate’
Intellectual Property 2018-06-05 10:14 pm By Miklos Bolza

Three generic drug manufacturers cannot claim damages for an injunction barring the release of cheaper versions of Effexor-XR, even if the injunction was later overturned, […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Wyeth launches “ambush” at start of Effexor trial, court told
Intellectual Property 2018-06-04 10:13 pm By Miklos Bolza

Pharmaceutical giant Wyeth’s has launched an “ambush” at the beginning of a trial after a nine-year long battle against several generic drug makers, alleging infringement […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Wyeth faces trial over generic Effexor delay
Intellectual Property 2018-06-01 11:21 pm By Miklos Bolza

A decade-long courtroom battle over a patent for Effexor-XR that delayed the release of cheap versions of the anti-depressant is at the centre of a […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

GSK, Novartis concede more ground in ACCC’s Voltaren case
Competition & Consumer Protection 2018-03-06 8:07 pm By Cat Fredenburgh

GlaxoSmithKline and Novartis have made another admission in a case brought by the ACCC alleging the drug giants made misleading claims in marketing their Voltaren Osteo […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

AstraZeneca resolves Crestor patent spat with Generic Health
Intellectual Property 2018-03-01 7:23 pm By Christine Caulfield

Pharmaceutical companies AstraZeneca and Generic Health have laid down their swords in a long-running patent dispute over AstraZeneca’s cholesterol drug Crestor, two-and-a-half years after the […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

GSK admits old Voltaren label was misleading
Competition & Consumer Protection 2018-02-19 8:43 pm By Christine Caulfield

Drug giants GlaxoSmithKline and Novartis have conceded part of the ACCC’s case that packaging on their Voltaren Osteo Gel breached the Australian Consumer Law, but […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

LG appeal to clarify murky area of consumer law
Competition & Consumer Protection 2017-11-03 2:46 pm By Cat Fredenburgh

The ACCC will have another go at its case against electronics giant LG next May, according to an order Thursday, and its appeal gives the […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.